This is a demo store. No orders will be fulfilled.
Vital Signs The Analyst's Perspective - June 2016 Issue
Vital Signs The Analyst's Perspective - June 2016 Issue
RELEASE DATE
02-Aug-2016
02-Aug-2016
REGION
Global
Global
Deliverable Type
Market Research
Market Research
Research Code: 9A35-00-4D-00-00
SKU: HC02668-GL-MR_18826
$450.00
In stock
SKU
HC02668-GL-MR_18826
Description
This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
Table of Contents
June 2016 Issue
Popular Topics
This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
Deliverable Types | Market Research |
---|---|
No Index | No |
Podcast | No |
Author | Christi Bird |
Industries | Healthcare |
WIP Number | 9A35-00-4D-00-00 |
Is Prebook | No |